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Chloroma, or granulocytic sarcoma, is a rare extramedullary solid hematologic cancer that affects many
sites, usually in concert with acute myeloid leukemia. It is infrequently associated with other
myeloproliferative disorders or chronic myelogenous leukemia. Chloroma of the testis after allogeneic
bone marrow transplantation is particularly sparsely represented in the literature. It is often incorrectly
diagnosed as malignant lymphoma, especially large-cell lymphoma, owing to the similarity of the histo-
logic morphology, scanty eosinophilic myelocytes, and no or overlooked history of leukemia. Although
erroneous diagnosis is decreasing with the advent of ancillary studies, the diagnosis of chloroma con-
tinues to be a nightmare for pathologists. It is thus suggested that an appropriate panel of marker studies
be performed in conjunction with clinical correlation and circumspection to avoid reaching a misleading
conclusion and improper treatment of patients. We report an interesting case of a 35-year-old male with
a clinical history of chronic myelogenous leukemia post allogeneic peripheral blood stem cell transplan-
tation and complete molecular remission, who was found to have chloroma of the left testis.
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Chloroma, or granulocytic sarcoma, is a rare extramedullary
solid hematologic tumor composed of primitive myeloid
cells and their granulocytic precursor cells [1–3]. It is found
concomitant with any form of myelodysplastic syndrome,
myeloproliferative disorder, or acute or chronic myeloid
leukemia [4]. Several sites of the body may be affected,
including head and neck, limbs, trunk, body cavities, sex
glands, and mammary glands, among which bone, skin,
soft tissue, periosteum, and lymph nodes are the most
common locations involved [1–5]. Chloroma in the testis is
a peculiar presenting site [3,6]. Its occurrence as relapse of
chronic myelogenous leukemia (CML) after allogeneic bone
marrow transplant is an extremely singular event and, to
the best of our knowledge, there are only a few reports in the
literature [7–10]. Here, we present the rare case of a 35-year-
old man with reactivation of CML following allogeneic
peripheral blood stem cell transplantation (PBSCT).
CASE PRESENTATION
A 35-year-old male patient with a history of CML presented
with a progressively enlarged and tender left testis over
approximately 3 months. Tracing his history, he had had
initial symptoms and signs of fever, general weakness,
night sweating, and weight loss of 5–6 kg in 2–3 months ap-
proximately 13 months previously. He had been admitted
to hospital due to black stool and loss of consciousness. Af-
ter serial examinations, he was diagnosed as having CML
Chloroma after allogeneic PBSCT
507Kaohsiung J Med Sci October 2004 • Vol 20 • No 10
and received allogeneic PBSCT 7 months before the cur-
rent presentation. He was in complete molecular remis-
sion without systemic relapse of CML thereafter. On phy-
sical examination, he had no fever or chills and only a
progressively enlarged hard nodule with local heat and
tenderness in the left testis. Alpha-fetoprotein, lactate de-
hydrogenase, and beta-human chorionic gonadotropin
were all within normal limits. Aerobic and anaerobic bac-
terial cultures of aspiration fluid from the affected testis
failed to demonstrate any infectious agents. Repeated cy-
togenetic analyses showed normal male karyotype with-
out any chromosomal abnormalities. Repeated periph-
eral blood smear studies revealed normal white blood
cell and platelet counts without any evidence of a re-
lapse of leukemia. Bone marrow aspiration comprised
normal erythroid series, adequate megakaryocytes, and
adequate maturation of myeloid series. Bone marrow bi-
opsy showed normocellular marrow with unremarkable
lineages of hematopoietic cells. Serial ultrasonography
of the left testis during follow-up demonstrated an in-
creasingly enlarged heterogeneous mass (Figure 1). Ma-
lignancy or infectious disease were clinically suspected.
The patient underwent left radical orchiectomy. On
cross-section, a firm and heterogeneous tumor with a light-
yellow, grayish-white to cream-colored appearance effaced
the whole normal architecture of the testis, and measured
3.8 × 2.5 × 3.6 cm (Figure 2). Histopathologic examina-
tion of the testis revealed diffuse infiltration of immature
monotonous large hyperchromatic neoplastic cells with
scanty cytoplasm and round-to-oval nuclei, effacing the
normal testicular architecture and spermatic cord with
areas of necrosis (Figure 3). Interspersed within these
neoplastic cells were eosinophilic myelocytes, which were
extremely scarce and only haphazardly found if carefully
sought, and were therefore easily missed (Figure 4). Re-
peated immunohistochemical studies consistently mani-
fested the expression of lysozyme, CD68, CD34, CD117
(c-Kit), vimentin, and leukocyte common antigen, but
not of B-cell-specific (CD20) or T-cell-specific antigens
(CD3), cytokeratin, periodic acid Schiff (PAS), and epi-
thelial membrane antigen. The patient received regular
follow-up and chemotherapy in the outpatient depart-
ment for 3 months.
Figure 1. Ultrasonography demonstrates a heterogeneous hypoechoic
mass in the left testis.
Figure 3. Diffuse monotonous large hyperchromatic neoplastic cells
with scanty cytoplasm effacing normal testicular architecture (hematoxy-
lin & eosin, original magnification × 40).
Figure 2. Light yellow to cream-colored, heterogeneous, firm tumor on
cross-section of the testis.
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DISCUSSION
Chloroma is also known as granulocytic sarcoma or mye-
loblastoma. It is a rarely encountered variant of myeloid
malignancy defined as extramedullary myeloblasts and
their granulocytic precursor cells at various levels of gran-
ulocytic differentiation [11–14]. Several sites of the body
have been affected, and erratic sites such as the brain, me-
diastinum, gastrointestinal tract, and testis are also de-
scribed in the literature. The original name, chloroma, was
first used by King in 1853 because of the characteristic
greenish facade produced by the enzyme myeloperoxi-
dase [11]. The epidemiology of these tumors is uncertain
and quite difficult to study. A prevalence of 4% was re-
ported in patients with CML in one autopsy series, while
other retrospective studies have reported an incidence
of between 3% and 5% [11]. Translocation t(8:21)(q22:
q22) is the most common cytogenetic abnormality in leu-
kemia patients with chloroma [11]. In this case, repeated
chromosomal studies at different time intervals showed
a normal karyotype.
Chloroma mostly occurs with acute myeloid leukemia
(AML), but has also been documented in CML patients [4,
10,15]. It may occur without other hematologic disorders,
during the course of, or preceding the onset of other hema-
tologic disorders such as AML [4]. When it occurs with-
out preceding leukemia history, no evidence of any abnor-
mality in the bone marrow or peripheral blood, or is not
suspected by the clinician, the diagnosis of chloroma al-
ways requires much effort and circumspection. Thus, it
is frequently missed from the pathologist’s list of differen-
tial diagnoses [16].
A combination of histopathologic findings, clinical his-
tory, and a panel of antibodies in immunohistochemistry is
mandatory for a correct diagnosis of chloroma [15,17–21].
Differential diagnoses include infectious process, poorly
differentiated carcinoma, malignant lymphoma, and sem-
inoma. Without identification of any microorganism by
laboratory data or aerobic and anaerobic cultures, an infec-
tious process was less favored over malignancy in this case.
However, it is still challenging to distinguish chloroma
from malignant lymphoma and other poorly differentiated
carcinoma or malignancy, chiefly because of the similar
histopathologic features on hematoxylin and eosin sec-
tions, without other ancillary studies. Repeated immuno-
histochemical studies with a panel of antibodies were per-
formed in this case and disclosed expression of lysozyme,
CD68, CD34, CD117, vimentin, and leukocyte common
antigen, but not of B-cell-specific (CD20) or T-cell-specific
antigens (CD3), cytokeratin, PAS, and epithelial membrane
antigen. Poorly differentiated carcinoma is unlikely because
of the negative cytokeratin result. Neoplasia is quite of-
ten misdiagnosed as malignant lymphoma, especially non-
Hodgkin’s lymphoma and large-cell lymphoma, solely
based on morphologic features because of the similar
histopathologic picture [1,4,15,17,22]. The expression of
leukocyte common antigen without expression of B-cell-
specific (CD20) and T-cell-specific antigens (CD3) made
malignant lymphoma less likely. Seminoma must also
be considered here because it is the most commonly en-
countered cancer in the testis [23]. However, the lack of
PAS immunoreactivity and no clear and vacuolated cyto-
plasm excluded the possibility of seminoma [24,25]. Lyso-
zyme and CD117 are among the most sensitive immuno-
histochemical markers for extramedullary myeloid cells,
while myeloperoxidase stains a smaller proportion of
poorly differentiated and blastic subtypes with varied fo-
cal staining, depending on the type of chloroma or individ-
ual cases [17,19,26]. In this case, histopathologic findings
comprised overwhelming monotonous hyperchromatic
cells with scanty cytoplasm and sparse eosinophilic myelo-
cytes, a helpful diagnostic clue but not always found in
other cases. Hence, chloroma was the final diagnosis from
the histopathologic findings, clinical history, and immuno-
histochemistry.
Ultrasonography is now a helpful tool for detecting the
size, morphology, vascularity, extension, and texture of tes-
ticular lesions. However, the ultrasonographic features
of testicular chloroma and other testicular lesions such as
Figure 4. High-power magnification of monotonous cancer cells scattered
with a few eosinophilic myelocytes (hematoxylin & eosin, original mag-
nification × 400).
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metastasis, seminoma, lymphoma, and other tumors are
similar and indistinguishable. To our knowledge, sonogra-
phic features of testicular chloroma have rarely been re-
ported, with only one reported case found in the litera-
ture [27]. The ultrasonographic findings of testicular lym-
phoma and leukemia in the literature were hypoechoic tex-
ture, solitary, multifocal, or hypervascular lesions regard-
less of size. A basket-like appearance with a low resis-
tive index was also reported in the ultrasonographic find-
ings of testicular lymphoma. Chiou et al reported a
smooth border and homogeneous echo texture in testi-
cular chloroma [27]. However, in our case, the sonographic
features were heterogeneous and not similar to those re-
ported in the literature. Hence, the sonographic features in
this case were not helpful in the differential diagnosis.
Our patient achieved hematologic remission, but the
disease was reactivated as a chloroma after allogeneic
PBSCT. Its occurrence exhibits a worse outcome, espe-
cially after allogeneic PBSCT [5,13,28–30]. Chloroma is
very clever at imitating other diseases [26]. Optimal treat-
ment needs to be worked out [5]. Some patients have
chemotherapy [2,3,29], while others have combined che-
motherapy and radiotherapy [13,30]. Our patient received
chemotherapy and had regular follow-up in the outpatient
department for 3 months. We present the case not only
for its rarity but also to alert physicians to the importance
of a high index of suspicion for chloroma in the differen-
tial diagnosis of other diseases, such as extramedullary
hematopoiesis, infectious diseases, poorly differentiated
carcinoma, melanoma, T-cell lymphoma, lymphoblastic
lymphoma, Hodgkin’s disease, and non-Hodgkin’s large-
cell lymphoma, to render a correct diagnosis and proper
treatment [2,16,26].
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